Most Do Not Want the Supreme Court to Overturn the ACA or its Pre-Existing Conditions Protections When it comes to tackling pressing health care issues, incremental actions to address personal health care costs take precedence over broader, more partis…
Most Do Not Want the Supreme Court to Overturn the ACA or its Pre-Existing Conditions Protections When it comes to tackling pressing health care issues, incremental actions to address personal health care costs take precedence over broader, more partis…
This analysis for the Peterson-Kaiser Health System Tracker uses information from the Current Population Survey to look at the average amounts and the shares of family income people in working families with employer-based coverage pay out-of-pocket tow…
This analysis looks at the share of working families’ income that is spent on premiums, deductibles and other cost-sharing for employer-sponsored care. It shows that lower-income families spend a greater share of their income on health costs than those…
In this Axios column, Drew Altman shows that employer coverage for lower wage workers is much worse than ACA marketplace coverage for similar populations. It’s a bigger problem we need to talk about more, he says.
In this Axios column, Drew Altman shows that employer coverage for lower wage workers is much worse than ACA marketplace coverage for similar populations. It’s a bigger problem we need to talk about more, he says.
Medicare Part D spending on insulin increased 840 percent between 2007 and 2017, far outpacing growth in the number of beneficiaries using insulin therapy, according to a new KFF analysis. The findings come at a time when the cost of prescription drugs…
Medicare Part D spending on insulin increased 840 percent between 2007 and 2017, far outpacing growth in the number of beneficiaries using insulin therapy, according to a new KFF analysis. The findings come at a time when the cost of prescription drugs…
The price of insulin, used by people with both Type 1 and Type 2 diabetes to control blood glucose levels, has come under increasing scrutiny as policymakers grapple with rising drug costs. This data note finds spending on insulin by Medicare and benef…
The price of insulin, used by people with both Type 1 and Type 2 diabetes to control blood glucose levels, has come under increasing scrutiny as policymakers grapple with rising drug costs. This data note finds spending on insulin by Medicare and benef…
